The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

Cancer statistics, 1993

C. C. Boring, T. S. Squires, T. Tong · CA A Cancer Journal for Clinicians · 1993 · 981 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study

W.J. Hoskins, Brian N. Bundy, J.T. Thigpen et al. · Gynecologic Oncology · 1992 · 553 citations

Medicine, Oncology, Surgery +16

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.

G Omura, Mark F. Brady, Howard D. Homesley et al. · Journal of Clinical Oncology · 1991 · 469 citations

Medicine, Gynecology, Oncology +16

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.

G A Omura, B. Bundy, Jonathan S. Berek et al. · Journal of Clinical Oncology · 1989 · 327 citations

Medicine, Gynecology, Oncology +17

Advanced Ovarian Adenocarcinoma

Robert C. Young, Bruce A. Chabner, Susan P. Hubbard et al. · New England Journal of Medicine · 1978 · 322 citations

Medicine, Oncology, Pharmacology +16